.webp)
plushcare compounded semaglutide Wegovy® Weight Loss Prescription Online PlushCare Tirzepatide: Program Details, Pricing,
Description
The Needle-Averse Market is Massive A survey of over 1,000 adults living with obesity found that 71% would prefer a daily pill over a weekly injection when choosing a prescription weight-loss medication
Analysts project the GLP-1 obesity and diabetes market will reach somewhere between $100 billion and $200 billion by 2030, depending on pricing dynamics and oral formulation uptake
Medication may help reduce the constant urge to snack, making or eating smaller portions, and support better control around meals
Treatment will need to be chronic
